SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

SafetyLit Journal Details

We are unable to provide photocopies of any the articles and reports abstracted in SafetyLit updates. Where possible, links have been provided to the publisher of the material and contact information for the corresponding author is listed. Please consider asking your library to subscribe to the journals from which these abstracts have been gathered.

To recommend a journal for this list please: Send SafetyLit an Email Message


Biomarkers in neuropsychiatry

Abbreviation: Biomark. Neuropsychiatry

Published by: Elsevier Publishing

Publisher Location: Amsterdam, Netherlands

Journal Website:
https://www.sciencedirect.com/journal/biomarkers-in-neuropsychiatry


Range of citations in the SafetyLit database: 2020; ePub(ePub) -- 2020; ePub(ePub)

Publication Date Range: 2019 --

Title began with volume (issue): 1()

Number of articles from this journal included in the SafetyLit database: 1
(Download all articles from this journal in CSV format.)

pISSN = 2666-1446


Find a library that holds this journal: http://worldcat.org/issn/26661446

Journal Language(s): English


Aims and Scope (from publisher): Biomarkers in Neuropsychiatry is an international, peer-review, rapid-publication and open access journal published by Elsevier. It is dedicated to disseminating original data, systematic reviews and meta-analyses focusing on neurobiologic, therapeutic or prognostic biomarkers associated with all brain disorders, neurologic and/or psychiatric. The Journal will consider submissions related to a wide array of genetic, molecular, neuroimaging (MRI, MRS, fMRI and DTI), neurophysiological, neurochemical, endocrinological and immunological biomarkers, related to brain structure or function in all neuropsychiatric disorders. The Journal encourages interdisciplinary research collaboration across multiple scientific disciplines because that often facilitates the generation of breakthrough insights and novel biomarkers.